Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Cryosite Limited ( (AU:CTE) ) has provided an announcement.
Cryosite Limited has reported strong financial performance for the first half of FY25, with notable increases in revenue and EBITDA, driven by high-margin services and controlled costs. The company has completed a significant expansion of its South Granville facility, doubling its capacity for freezers and liquid nitrogen tanks, positioning it for further growth in the biological storage sector.
More about Cryosite Limited
Cryosite Limited operates in the biological storage industry, offering high-margin services such as inbound, storage, and outbound activities. The company is focused on expanding its footprint in the biological storage space, catering to clients like clinical research organizations, pharmaceutical companies, and biotechnology firms involved in clinical trials.
YTD Price Performance: -8.24%
Average Trading Volume: 2,750
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$38.07M
For an in-depth examination of CTE stock, go to TipRanks’ Stock Analysis page.
